Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Evidence for Env-V2 sieve effe...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Evidence for Env-V2 sieve effect in breakthrough SIV <sub>MAC251</sub> infections in rhesus monkeys vaccinated with Ad26/MVA and MVA/Ad26 constructs

Evidence for Env-V2 sieve effect in breakthrough SIV <sub>MAC251</sub> infections in rhesus monkeys vaccinated with Ad26/MVA and MVA/Ad26 constructs

Bibliographic Details
Main Authors: Sina S, Tovanabutra S, Sanders-Buell E, Bates A, Bose M, Howell S, Ibitamuno G, Lazzaro M, O'Sullivan A, Lee J, Cervenka T, Kuroiwa J, Baldwin K, Barouch DH, Robb M, O'Connell R, Michael NL, Kim JH, Rolland M
Format: Article
Language:English
Published: BMC 2012-09-01
Series:Retrovirology
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques
    by: John D. Ventura, et al.
    Published: (2022-05-01)
  • Durability of immune responses induced by three leading candidate ebola vaccine regimes; rVSV ZEBOV, ChAd3 EBO Z-MVA BN-Filo and AdHu26.ZEBOV-MVA BN Filo
    by: Ewer, K, et al.
    Published: (2018)
  • PP 8.6 – 00089 Ad26/MVA Mosaic vaccine induced antibody responses with limited cross-reactivity to CRF01_AE infections
    by: T. Mdluli, et al.
    Published: (2022-12-01)
  • Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen
    by: Viki Bockstal, et al.
    Published: (2021-12-01)
  • Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen.
    by: Houreratou Barry, et al.
    Published: (2024-04-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs